From September 17–19, 2025, Vitafoods Asia, the leading nutraceutical event in the Asia-Pacific region, was held at the Queen Sirikit National Convention Center in Bangkok, Thailand. Seno Biotech, an innovative Chinese nutrition and health company, made its international debut with the launch of its flagship product Egg White Isolate, capturing widespread industry attention and signing multiple strategic agreements with overseas partners. The milestone marks a major step forward in the company’s globalization strategy.

Redefining the Protein Powder Standard

As the spotlight of the show, Egg White Isolate embodies “Purity, Efficiency, and Science,” overcoming the limitations of conventional protein powders with four key advantages:

• High Digestibility: DIAAS score above 100, demonstrating excellent amino acid availability.

• Complete Amino Acid Profile: Provides all 18 essential amino acids with ratios aligned to human needs.

• Functional Enhancement: Enriched with BCAAs and sulfur-containing amino acids to support muscle building, metabolism, and immune health.

• Low-Sodium Innovation: 65% sodium reduction, answering global demand for low-salt and clean-label products.

According to Seno Biotech’s R&D director, “Egg White Isolate reflects not only our expertise in protein extraction and functionalization but also the global drive for clean-label and high-quality protein nutrition. Our goal is to set a new industry benchmark.”

Accelerating International Expansion

Vitafoods Asia attracted professional buyers from over 80 countries. With an exhibition booth themed “Technology + Nature,” Seno Biotech engaged visitors through interactive demos and product tastings. The company secured memorandums of understanding with five international distributors from Southeast Asia, Europe, and North America, covering sports nutrition, dietary supplements, and healthy aging applications.

A European buyer commented: “Both the technical specifications and the taste profile of Egg White Isolate exceeded expectations. We are excited to introduce it to the European market.”

Driving Industry Upgrades

Founded in 2017, Seno Biotech is dedicated to research and application of natural egg-derived bioactives and holds multiple core patents. Its participation in Vitafoods Asia marks a key milestone in internationalization, showcasing the transformation of Chinese nutrition health companies from “manufacturing” to “smart manufacturing.”

The company’s General Manager stated: “Over the next three years, we will further increase our overseas R&D investment and strengthen collaboration with global research institutions. Our mission is to develop holistic, life-cycle health ingredient solutions and contribute to the advancement of global nutrition.”